Loading…

Fibroscan and FibroTest/FibroMax to assess liver fibrosis/cirrhosis in patients with chronic HBV and HCV infection in Georgia

Although, liver biopsy is the gold standard in assessment of the degree of liver damage, the method has some limitations. For this reason, assessment of liver damage using non-invasive methods is currently an important topic in hepatology. The aim of the study was to evaluate liver fibrosis/cirrhosi...

Full description

Saved in:
Bibliographic Details
Published in:Georgian medical news 2008-12 (165), p.83-87
Main Authors: Dolmazashvili, E, Zhamutashvili, M, Svanidze, M, Nizharadze, N, Abutidze, A
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 87
container_issue 165
container_start_page 83
container_title Georgian medical news
container_volume
creator Dolmazashvili, E
Zhamutashvili, M
Svanidze, M
Nizharadze, N
Abutidze, A
description Although, liver biopsy is the gold standard in assessment of the degree of liver damage, the method has some limitations. For this reason, assessment of liver damage using non-invasive methods is currently an important topic in hepatology. The aim of the study was to evaluate liver fibrosis/cirrhosis using Transient Elastography and FibroTest/FibroMax in patients with chronic HCV and HBV infection in Georgia and to compare Fibroscan and FibroTest/FibroMax results. 252 patients were included in the study, among them 185 with chronic HCV infection and 67 with chronic HBV infection. These patients were investigated at the Georgian-French Joint Hepatology Clinic "Hepa", from December 2007 to November 2008. In patients with chronic HCV or HBV infection Fibroscan and Fibrotest/FibroMax results were correlated in 127 (68.6%) and 45 (67.2%) cases, respectively. Discordance in one degree of fibrosis stage was found in 36 (19.5%) patients with chronic HCV infection and in 14 (20.9%) patients with chronic HBV infection. Discordance in more then one degree of fibrosis stage was found in 22 (11.9%) and 8 (11.9%) cases. In patients with Fibroscan and Fibrotest/FibroMax concordant results liver biopsy might be avoided. Fibroscan and Fibrotest/Max appear to be very valuable methods for detecting early stages of fibrosis among patients with chronic HCV and HBV infection, allowing to avoid the progression of liver damage, as well as end-stage liver disease. These methods are easy to perform and therefore allows regular follow-up of the course of LF.
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_69937685</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>69937685</sourcerecordid><originalsourceid>FETCH-LOGICAL-p124t-adfaefd882d0fac0c973a7bf0d89ec061bb5fb03eea98cbc77ec4e07f591caf43</originalsourceid><addsrcrecordid>eNo1kMtOwzAQRb0A0ar0F5BX7KLaeXsJFW2RitiUbqOxMyZGqR3slMeCfycNZTZzRzpzdWcuyJRnPI4Y5_GEzEN4Y0NlaV7y9IpMuOBxKuJkSn5WRnoXFFgKtqbjtMPQL0b1BF-0dxRCwBBoaz7QUz0umLBQxvvmpKixtIPeoO0D_TR9Q1XjnTWKbu73o-1muR8gjao3zp7wNTr_auCaXGpoA87PfUZeVg-75SbaPq8fl3fbqBty9hHUGlDXZRnXTINiShQJFFKzuhSoWM6lzLRkCSKIUklVFKhSZIXOBFeg02RGbv98O-_ej8N51cEEhW0LFt0xVLkQSZGX2QDenMGjPGBddd4cwH9X_w9LfgGGT2ol</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69937685</pqid></control><display><type>article</type><title>Fibroscan and FibroTest/FibroMax to assess liver fibrosis/cirrhosis in patients with chronic HBV and HCV infection in Georgia</title><source>Elektronische Zeitschriftenbibliothek - Freely accessible e-journals</source><creator>Dolmazashvili, E ; Zhamutashvili, M ; Svanidze, M ; Nizharadze, N ; Abutidze, A</creator><creatorcontrib>Dolmazashvili, E ; Zhamutashvili, M ; Svanidze, M ; Nizharadze, N ; Abutidze, A</creatorcontrib><description>Although, liver biopsy is the gold standard in assessment of the degree of liver damage, the method has some limitations. For this reason, assessment of liver damage using non-invasive methods is currently an important topic in hepatology. The aim of the study was to evaluate liver fibrosis/cirrhosis using Transient Elastography and FibroTest/FibroMax in patients with chronic HCV and HBV infection in Georgia and to compare Fibroscan and FibroTest/FibroMax results. 252 patients were included in the study, among them 185 with chronic HCV infection and 67 with chronic HBV infection. These patients were investigated at the Georgian-French Joint Hepatology Clinic "Hepa", from December 2007 to November 2008. In patients with chronic HCV or HBV infection Fibroscan and Fibrotest/FibroMax results were correlated in 127 (68.6%) and 45 (67.2%) cases, respectively. Discordance in one degree of fibrosis stage was found in 36 (19.5%) patients with chronic HCV infection and in 14 (20.9%) patients with chronic HBV infection. Discordance in more then one degree of fibrosis stage was found in 22 (11.9%) and 8 (11.9%) cases. In patients with Fibroscan and Fibrotest/FibroMax concordant results liver biopsy might be avoided. Fibroscan and Fibrotest/Max appear to be very valuable methods for detecting early stages of fibrosis among patients with chronic HCV and HBV infection, allowing to avoid the progression of liver damage, as well as end-stage liver disease. These methods are easy to perform and therefore allows regular follow-up of the course of LF.</description><identifier>ISSN: 1512-0112</identifier><identifier>PMID: 19124923</identifier><language>eng</language><publisher>Georgia (Republic)</publisher><subject>Elasticity Imaging Techniques - instrumentation ; Hepatitis B, Chronic - complications ; Hepatitis C, Chronic - complications ; Humans ; Liver Cirrhosis - etiology ; Liver Cirrhosis - pathology</subject><ispartof>Georgian medical news, 2008-12 (165), p.83-87</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19124923$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Dolmazashvili, E</creatorcontrib><creatorcontrib>Zhamutashvili, M</creatorcontrib><creatorcontrib>Svanidze, M</creatorcontrib><creatorcontrib>Nizharadze, N</creatorcontrib><creatorcontrib>Abutidze, A</creatorcontrib><title>Fibroscan and FibroTest/FibroMax to assess liver fibrosis/cirrhosis in patients with chronic HBV and HCV infection in Georgia</title><title>Georgian medical news</title><addtitle>Georgian Med News</addtitle><description>Although, liver biopsy is the gold standard in assessment of the degree of liver damage, the method has some limitations. For this reason, assessment of liver damage using non-invasive methods is currently an important topic in hepatology. The aim of the study was to evaluate liver fibrosis/cirrhosis using Transient Elastography and FibroTest/FibroMax in patients with chronic HCV and HBV infection in Georgia and to compare Fibroscan and FibroTest/FibroMax results. 252 patients were included in the study, among them 185 with chronic HCV infection and 67 with chronic HBV infection. These patients were investigated at the Georgian-French Joint Hepatology Clinic "Hepa", from December 2007 to November 2008. In patients with chronic HCV or HBV infection Fibroscan and Fibrotest/FibroMax results were correlated in 127 (68.6%) and 45 (67.2%) cases, respectively. Discordance in one degree of fibrosis stage was found in 36 (19.5%) patients with chronic HCV infection and in 14 (20.9%) patients with chronic HBV infection. Discordance in more then one degree of fibrosis stage was found in 22 (11.9%) and 8 (11.9%) cases. In patients with Fibroscan and Fibrotest/FibroMax concordant results liver biopsy might be avoided. Fibroscan and Fibrotest/Max appear to be very valuable methods for detecting early stages of fibrosis among patients with chronic HCV and HBV infection, allowing to avoid the progression of liver damage, as well as end-stage liver disease. These methods are easy to perform and therefore allows regular follow-up of the course of LF.</description><subject>Elasticity Imaging Techniques - instrumentation</subject><subject>Hepatitis B, Chronic - complications</subject><subject>Hepatitis C, Chronic - complications</subject><subject>Humans</subject><subject>Liver Cirrhosis - etiology</subject><subject>Liver Cirrhosis - pathology</subject><issn>1512-0112</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><recordid>eNo1kMtOwzAQRb0A0ar0F5BX7KLaeXsJFW2RitiUbqOxMyZGqR3slMeCfycNZTZzRzpzdWcuyJRnPI4Y5_GEzEN4Y0NlaV7y9IpMuOBxKuJkSn5WRnoXFFgKtqbjtMPQL0b1BF-0dxRCwBBoaz7QUz0umLBQxvvmpKixtIPeoO0D_TR9Q1XjnTWKbu73o-1muR8gjao3zp7wNTr_auCaXGpoA87PfUZeVg-75SbaPq8fl3fbqBty9hHUGlDXZRnXTINiShQJFFKzuhSoWM6lzLRkCSKIUklVFKhSZIXOBFeg02RGbv98O-_ej8N51cEEhW0LFt0xVLkQSZGX2QDenMGjPGBddd4cwH9X_w9LfgGGT2ol</recordid><startdate>200812</startdate><enddate>200812</enddate><creator>Dolmazashvili, E</creator><creator>Zhamutashvili, M</creator><creator>Svanidze, M</creator><creator>Nizharadze, N</creator><creator>Abutidze, A</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>200812</creationdate><title>Fibroscan and FibroTest/FibroMax to assess liver fibrosis/cirrhosis in patients with chronic HBV and HCV infection in Georgia</title><author>Dolmazashvili, E ; Zhamutashvili, M ; Svanidze, M ; Nizharadze, N ; Abutidze, A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p124t-adfaefd882d0fac0c973a7bf0d89ec061bb5fb03eea98cbc77ec4e07f591caf43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Elasticity Imaging Techniques - instrumentation</topic><topic>Hepatitis B, Chronic - complications</topic><topic>Hepatitis C, Chronic - complications</topic><topic>Humans</topic><topic>Liver Cirrhosis - etiology</topic><topic>Liver Cirrhosis - pathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dolmazashvili, E</creatorcontrib><creatorcontrib>Zhamutashvili, M</creatorcontrib><creatorcontrib>Svanidze, M</creatorcontrib><creatorcontrib>Nizharadze, N</creatorcontrib><creatorcontrib>Abutidze, A</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Georgian medical news</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dolmazashvili, E</au><au>Zhamutashvili, M</au><au>Svanidze, M</au><au>Nizharadze, N</au><au>Abutidze, A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Fibroscan and FibroTest/FibroMax to assess liver fibrosis/cirrhosis in patients with chronic HBV and HCV infection in Georgia</atitle><jtitle>Georgian medical news</jtitle><addtitle>Georgian Med News</addtitle><date>2008-12</date><risdate>2008</risdate><issue>165</issue><spage>83</spage><epage>87</epage><pages>83-87</pages><issn>1512-0112</issn><abstract>Although, liver biopsy is the gold standard in assessment of the degree of liver damage, the method has some limitations. For this reason, assessment of liver damage using non-invasive methods is currently an important topic in hepatology. The aim of the study was to evaluate liver fibrosis/cirrhosis using Transient Elastography and FibroTest/FibroMax in patients with chronic HCV and HBV infection in Georgia and to compare Fibroscan and FibroTest/FibroMax results. 252 patients were included in the study, among them 185 with chronic HCV infection and 67 with chronic HBV infection. These patients were investigated at the Georgian-French Joint Hepatology Clinic "Hepa", from December 2007 to November 2008. In patients with chronic HCV or HBV infection Fibroscan and Fibrotest/FibroMax results were correlated in 127 (68.6%) and 45 (67.2%) cases, respectively. Discordance in one degree of fibrosis stage was found in 36 (19.5%) patients with chronic HCV infection and in 14 (20.9%) patients with chronic HBV infection. Discordance in more then one degree of fibrosis stage was found in 22 (11.9%) and 8 (11.9%) cases. In patients with Fibroscan and Fibrotest/FibroMax concordant results liver biopsy might be avoided. Fibroscan and Fibrotest/Max appear to be very valuable methods for detecting early stages of fibrosis among patients with chronic HCV and HBV infection, allowing to avoid the progression of liver damage, as well as end-stage liver disease. These methods are easy to perform and therefore allows regular follow-up of the course of LF.</abstract><cop>Georgia (Republic)</cop><pmid>19124923</pmid><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1512-0112
ispartof Georgian medical news, 2008-12 (165), p.83-87
issn 1512-0112
language eng
recordid cdi_proquest_miscellaneous_69937685
source Elektronische Zeitschriftenbibliothek - Freely accessible e-journals
subjects Elasticity Imaging Techniques - instrumentation
Hepatitis B, Chronic - complications
Hepatitis C, Chronic - complications
Humans
Liver Cirrhosis - etiology
Liver Cirrhosis - pathology
title Fibroscan and FibroTest/FibroMax to assess liver fibrosis/cirrhosis in patients with chronic HBV and HCV infection in Georgia
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-14T19%3A21%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Fibroscan%20and%20FibroTest/FibroMax%20to%20assess%20liver%20fibrosis/cirrhosis%20in%20patients%20with%20chronic%20HBV%20and%20HCV%20infection%20in%20Georgia&rft.jtitle=Georgian%20medical%20news&rft.au=Dolmazashvili,%20E&rft.date=2008-12&rft.issue=165&rft.spage=83&rft.epage=87&rft.pages=83-87&rft.issn=1512-0112&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E69937685%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p124t-adfaefd882d0fac0c973a7bf0d89ec061bb5fb03eea98cbc77ec4e07f591caf43%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=69937685&rft_id=info:pmid/19124923&rfr_iscdi=true